Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers

1 Jan 2005

Abstract excerpt

Heterologous prime-boost vaccination has been shown to be an efficient way of inducing T cell responses in animals and in humans. We have used three vaccine vectors, naked DNA, modified vaccinia virus Ankara (MVA), and attenuated fowlpox strain, FP9, for prime-boost vaccination approaches against Plasmodium falciparum malaria in humans. In this study, we characterize, using two types of ELISPOT assays and FACS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Poxvirus research and outbreaks
Share to vaccines and immunoinformatics approaches
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15611270
DOI: 10.4049/jimmunol.174.1.449

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy VolunteersPMID 15611270Read ↗

Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length<i>Plasmodium falciparum</i>Circumsporozoite ProteinSemantic proximity Read ↗

Progress in DNA‐based heterologous prime‐boost immunization strategies for malariaSemantic proximity Read ↗

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineSemantic proximity Read ↗

Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African AdultsSemantic proximity Read ↗

Prime-boost strategies for malaria vaccine developmentSemantic proximity Read ↗

Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectorsSemantic proximity Read ↗

APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces Plasmodium falciparum-Specific Neutralizing Antibodies and T Cell ResponsesSemantic proximity Read ↗

Use of viral vectors for the development of vaccinesSemantic proximity Read ↗

Enhanced CD8+ T Cell Immune Responses and Protection Elicited against Plasmodium berghei Malaria by Prime Boost Immunization Regimens Using a Novel Attenuated Fowlpox VirusSemantic proximity Read ↗

Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunitySemantic proximity Read ↗

Single-Dose Protection against<i>Plasmodium berghei</i>by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron ASemantic proximity Read ↗

Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus AnkaraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.